
The Worldwide Market for Liquid Biopsy (by Analyte [ctDNA, cfDNA, Other], by Application - Screening/Drug Monitoring/Diagnostic, by Region [US, Europe, Asia, ROW] and by Type of Cancer)
Description
The Worldwide Market for Liquid Biopsy
This report covers the market for liquid biopsy, including cfDNA, CTC and other technologies. The market data in this report is segmented by those technologies type of cancer tested and by purpose - testing, screening, drug monitoring. Companies are profiled and the top ten companies are ranked and their recent activities detailed.
Companies covered Include:
This report covers the market for liquid biopsy, including cfDNA, CTC and other technologies. The market data in this report is segmented by those technologies type of cancer tested and by purpose - testing, screening, drug monitoring. Companies are profiled and the top ten companies are ranked and their recent activities detailed.
Companies covered Include:
cfDNA-based Liquid Biopsy
Adaptive Biotechnologies
Biodesix
Epigenomics
Foundation Medicine
Genomic Health
Guardant Health
Myriad Genetics
Pathway Genomics
Personal Genome Diagnostics
Qiagen
Roche Diagnostics
Sysmex-Inostics
Trovagene
In Development Projects
Adaptive Biotechnologies
Biocartis
Epigenomics
Exact Sciences
Foundation Medicine
Genomic Health
GRAIL
Inivata
Natera
CTC-based Liquid Biopsy
Biocept
Cynvenio Biosystems
Epic Sciences
GILUPI
Menarini-Silicon Biosystems
Qiagen
Angle
Biocept
Epic Sciences
Janssen Diagnostics
Extracellular Vesicles-based Liquid Biopsy
Biodesix
Exosome Diagnostics
Gensignia
Hologic
The report contains:
- Market Sizing
- Market Forecasts to 2021
- Products in Development
- Trends and Issues
- Company Profiles
- Market Segmentation (Analyte, Purpose, Cancer Type)
- Overview of Technologies
- World Markets Segmented By Region
Table of Contents
210 Pages
- Introduction
- Liquid Biopsy Technologies
- Industry Structure
- Liquid Biopsy Market Revenues and Forecast
- Introduction
- Current Major Liquid Biopsy Technologies
- Introduction
- Advantages and Limitations of ctDNA in Liquid Biopsy
- Current ctDNA-based Liquid Biopsy Tests
- cctDNA-based Liquid Biopsy Tests in Development
- Introduction
- Challenges in the Development of CTCs-based Liquid Biopsy Tests
- CTCs-based Liquid Biopsy Tests
- CTCs-based Liquid Biopsy Tests in Development
- Introduction
- Liquid Biopsy Tests Based on Extracellular Vesicles
- Introduction
- Tiers of Competition
- Competitive Factors
- Significant Market Trends
- Market Snapshot
- Market Forecast
- Circulating Tumor DNA
- Circulating Tumor Cells
- Extracellular Vesicles/ Other Analytes
- Therapy Guidance and Monitoring
- Diagnosis/ Screening
- Disease Prognosis
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Ovarian Cancer
- Prostate Cancer
- Other Cancers
- Top Ten Companies in the Liquid Biopsy Market
- Biocept, Inc.
- Epigenomics
- Foundation Medicine, Inc.
- Genomic Health
- Guardant Health, Inc.
- Menarini-Silicon Biosystems
- Myriad Genetics, Inc.
- NeoGenomics
- QIAGEN N.V.
- Roche Diagnostics
- Other Companies Activating in the Liquid Biopsy Market
- Angle, plc
- Biocartis
- Biodesix
- Cynvenio Biosystems
- Epic Sciences
- Exact Sciences
- Exosome Diagnostics, Inc.
- Gensignia
- GILUPI Gmbh
- GRAIL
- Hologic, Inc.
- Inivata
- MDxHealth
- Natera
- OncoCyte
- Pathway Genomics
- Personal Genome Diagnostics
- Resolution Biosciences
- Rosetta Genomics
- Sysmex-Inostics, Inc.
- Trovagene, Inc.
- Vermillion, Inc.
- VolitionRx
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.